Symmetry Peak Management LLC Ironwood Pharmaceuticals Inc Transaction History
Symmetry Peak Management LLC
- $91.4 Million
- Q4 2024
A detailed history of Symmetry Peak Management LLC transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Symmetry Peak Management LLC holds 96,600 shares of IRWD stock, worth $187,404. This represents 0.28% of its overall portfolio holdings.
Number of Shares
96,600Holding current value
$187,404% of portfolio
0.28%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding IRWD
# of Institutions
243Shares Held
163MCall Options Held
11.5MPut Options Held
12.9K-
Black Rock Inc. New York, NY22.9MShares$44.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$37.9 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$31.8 Million22.5% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$22.8 Million0.13% of portfolio
-
Armistice Capital, LLC New York, NY9.47MShares$18.4 Million0.59% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $297M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...